The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Match Group, Inc.
ACCESSWIRE Newsroom· 2025-01-17 15:45
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Match Group, Inc. ...
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Seaboard Corporation For Securities Fraud
ACCESSWIRE Newsroom· 2025-01-17 15:45
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Seaboard Corporation For Securities Fraud ...
To accelerate the exploration of new nuclear technologies, Duke Energy joins industry group vying for DOE grant
Prnewswire· 2025-01-17 15:44
Ensures nuclear energy remains core to its 'all of the above' energy generation strategy Aligns with Duke Energy's focus on reducing costs and risks for its customers, investors and operations while supporting long-term regional economic development Includes agreement to invest in activities to advance standard design and licensing of GE Hitachi's small modular reactor technology while gathering industry learnings and best practices CHARLOTTE, N.C., Jan. 17, 2025 /PRNewswire/ -- Duke Energy today announce ...
Palantir insiders dump over $40 million PLTR shares in 2025
Finbold· 2025-01-17 15:43
Corporate insiders were exceptionally quick to begin selling vast quantities of their companies’ stock as soon as 2025 began. Tesla’s (NASDAQ: TSLA) senior officers, for example, dumped more than $40 million worth of TSLA shares by January 13. Simultaneously, Nvidia’s (NASDAQ: NVDA) executive vice president of Worldwide Field Operations, Ajay K. Puri, executed one of the best-timed insider trades on record as he offloaded 36,695 NVDA shares at an average price of $151.10 – almost $2 above the chipmaker’s al ...
Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 – BIOA
GlobeNewswire· 2025-01-17 15:43
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In BioAge To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in BioAge between September 26, 2024 and January 7, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 17, 2025 (GLOBE ...
Colgate Advances 13% in a Year: To Buy or Not to Buy the Stock?
ZACKS· 2025-01-17 15:41
Stock Performance - Colgate-Palmolive Company (CL) shares appreciated 13.1% in the trailing 12 months, outperforming the Zacks Consumer Products – Staples industry's rise of 6% and the broader Zacks Consumer Staples sector's return of 0.2% [1] - The upswing was driven by strong pricing, funding-the-growth initiatives, and solid business momentum, leading to robust performance in Q3 2024 [3] Financial Metrics - Adjusted gross margin rose to 61.3% and adjusted operating profit margin increased to 21.5% in Q3 2024 [4] - Year-over-year earnings per share growth was achieved, driven by higher gross margins and improved pricing across all divisions except North America [5] - Organic sales growth was bolstered by increased volume and pricing, with every operating division reporting volume growth for the second consecutive quarter [5] Strategic Initiatives - The company's strategy of combining core and premium innovation with increased advertising investment and enhanced capabilities is driving brand strength and expanding household penetration [6] - Successful product launches include CO by Colgate, Colgate Elixir toothpaste, and Colgate enzyme whitening toothpaste [6] Outlook and Guidance - Management forecasts gross profit margin expansion on both GAAP and adjusted bases, driven by pricing gains and revenue-growth management initiatives [7] - Base Business's EPS is expected to increase 10-11% in 2024, with GAAP EPS rising by double digits [7] - Net sales growth is anticipated at 3-5%, with organic sales growth expected at 7-8% for 2024 [8] - Currency translations are expected to have a mid-single-digit negative impact on sales [8] Revised Estimates - The Zacks Consensus Estimate for CL's fiscal 2024 earnings has remained unchanged in the past 30 days [9] - For 2024, sales and EPS are expected to grow 3.9% and 11.2% year-over-year, respectively [9] - For 2025, sales and earnings are expected to grow 3.1% and 6.7% year-over-year, respectively [9] Challenges - The company faces macroeconomic instability and foreign currency headwinds [10] - Persistent inflation in raw materials and packaging costs has negatively impacted profitability [10] - North America's net sales dipped 1.9% year-over-year on an organic basis, with a 3.2% decrease in pricing offset by a 1.2% increase in volume [11] - Latin America's net sales fell 3.2% year-over-year due to unfavorable currency impacts [11] - Foreign currency fluctuations reduced total sales growth by 4.4% in Q3, with significant effects from Argentina and the Africa/Eurasia division [12] Final Thoughts - CL's robust pricing strategies, productivity initiatives, and innovations make the stock attractive for long-term investors [13] - Continuing challenges like macroeconomic instability and foreign currency headwinds act as deterrents, suggesting current investors retain their positions while new investors wait for a more favorable entry point [14]
Is ThredUp (TDUP) Outperforming Other Consumer Staples Stocks This Year?
ZACKS· 2025-01-17 15:41
For those looking to find strong Consumer Staples stocks, it is prudent to search for companies in the group that are outperforming their peers. Has ThredUp (TDUP) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.ThredUp is one of 181 companies in the Consumer Staples group. The Consumer Staples group currently sits at #13 within the Zacks Sector Rank. The Zacks Sector Ran ...
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
ZACKS· 2025-01-17 15:41
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Adaptive Biotechnologies (ADPT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Adaptive Biotechnologies is a member of the Medical sector. This group includes 1010 ...
Is National Fuel Gas Company (NFG) Stock Outpacing Its Oils-Energy Peers This Year?
ZACKS· 2025-01-17 15:41
For those looking to find strong Oils-Energy stocks, it is prudent to search for companies in the group that are outperforming their peers. Has National Fuel Gas (NFG) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Oils-Energy sector should help us answer this question.National Fuel Gas is one of 249 companies in the Oils-Energy group. The Oils-Energy group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank ...
Has Solaris Resources Inc. (SLSR) Outpaced Other Basic Materials Stocks This Year?
ZACKS· 2025-01-17 15:41
For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Solaris Resources Inc. (SLSR) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Basic Materials peers, we might be able to answer that question.Solaris Resources Inc. is a member of the Basic Materials sector. This group includes 235 individual stocks and currently holds a Zacks Sector Rank of #11. ...